Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in New Aquitaine.
NCT ID: NCT05355012
Last Updated: 2023-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
4505 participants
INTERVENTIONAL
2022-10-03
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interventions of Smoking Cessation During Pregnancy
NCT01210118
Computer-Assisted Intervention for Smoking During Pregnancy
NCT01028131
A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay
NCT01852617
Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women
NCT01872156
SKIP-IT Smoking Cessation in Pregnancy
NCT03272113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
The quantitative study is a stepped-wedge cluster randomized trial (SWCRT) with a transition phase (deployment). The duration of each period is set at 3 months.
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5A-QUIT-N intervention
The 5A-QUIT-N intervention can be defined as multilevel, i.e., it is based on a territorial organization with expected results at the level of professional practice (structuring of practices around the 5A method) and therefore of the care of pregnant women who smoke tobacco.
This project is based on three strategic axes:
* A gradation of the care offer
* Personalized care by developing specific treatment paths
* Coordination of territorial resources to support pregnant women in quitting smoking.
These elements will make it possible to propose a partnership-based, multi-professional, coordinated and integrated approach to the territory, supported by the technical resources and expertise available in the territory. It invites a majority of non-specialized actors to invest in the process of supporting pregnant women in quitting smoking, multiplying and potentiating their actions with this population.
5A organizational innovation
This project is based on three strategic axes:
* A gradation of the care offer allowing to adapt the means and resources mobilized on the territory
* Personalized care by developing specific treatment paths based on the risk factors and/or vulnerabilities of the pregnant woman
* Coordination of territorial resources to support pregnant women in quitting smoking These three key elements will make it possible to propose a partnership-based, multi-professional, coordinated and integrated approach to the territory, supported by the technical resources and expertise available in the territory. It invites a majority of non-specialized actors to invest in the process of supporting pregnant women in quitting smoking, multiplying and potentiating their actions with this population.
5A-QUIT-N control
Usual care in the care of pregnant women who smoke tobacco.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
5A organizational innovation
This project is based on three strategic axes:
* A gradation of the care offer allowing to adapt the means and resources mobilized on the territory
* Personalized care by developing specific treatment paths based on the risk factors and/or vulnerabilities of the pregnant woman
* Coordination of territorial resources to support pregnant women in quitting smoking These three key elements will make it possible to propose a partnership-based, multi-professional, coordinated and integrated approach to the territory, supported by the technical resources and expertise available in the territory. It invites a majority of non-specialized actors to invest in the process of supporting pregnant women in quitting smoking, multiplying and potentiating their actions with this population.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All institutions, structures and organizations and health professionals likely to participate in the follow-up of pregnant women
* All institutions, structures and organizations and health professionals specializing in addictology or tobaccoology
\- All pregnant women who have smoked tobacco (at least 2 times a week, for at least 1 week) during the pregnancy (including the period when she was unaware of the pregnancy)
* Have given birth in a New Aquitaine maternity hospital,
* Reside in New Aquitaine
* To have been followed for the pregnancy in the territory of the maternity of delivery
* To have used tobacco during (at least 2 times a week, for at least 1 week) the pregnancy (including the period when she was unaware of the pregnancy)
* Be over 18
* Have given free, informed and express consent
* Pilot territory (territory of attractiveness of the Arcachon maternity hospital)
The criteria for non-inclusion of women who have just given birth are:
* Not speaking French,
* Have COVID during delivery
* Use only electronic cigarettes,
* Under legal protection (guardianship, curatorship, safeguard of justice)
* Women giving birth under X
* Women giving birth to a stillborn baby
* Women having made a denial of pregnancy
* Women who have their child in neonatal intensive care
* Women who have been fully monitored for their pregnancy outside of New Aquitaine
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François Alla, Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux, Hôpital Saint-André
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2019/61
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.